表紙
市場調查報告書

調劑藥局的全球市場:產業分析,地區市場預測,用途,潛在性,市場佔有率,預測(2019年∼2025年)

Compounding Pharmacies Market Size By Therapeutic Area, Product, Application, Compounding Type, Sterility, Distribution Channel, Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2019-2025

出版商 Global Market Insights Inc. 商品編碼 555464
出版日期 內容資訊 英文 250 Pages
商品交期: 2-3個工作天內
價格
Back to Top
調劑藥局的全球市場:產業分析,地區市場預測,用途,潛在性,市場佔有率,預測(2019年∼2025年) Compounding Pharmacies Market Size By Therapeutic Area, Product, Application, Compounding Type, Sterility, Distribution Channel, Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2019-2025
出版日期: 2019年12月10日內容資訊: 英文 250 Pages
簡介

全球調劑藥局市場至2025年預計將成長到135億美元。

本報告提供全球調劑藥局市場調查,市場概要,各產品、用途、治療領域、殺菌類型、流通管道、地區的市場規模的變化與預測,市場佔有率,市場成長要素及阻礙因素分析,市場機會,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 調查手法

  • 調查手法
  • 出處

第2章 摘要整理

  • 全方位的產業分析
    • 事業趨勢
    • 產品趨勢
    • 用途趨勢
    • 治療領域趨勢
    • 流通管道趨勢
    • 殺菌法趨勢
    • 地區趨勢

第3章 產業洞察

  • 產業市場區隔
  • 產業規模與預測
  • 產業生態系統分析
    • 供應商矩陣
    • 流通管道分析
  • 對產業的影響力
    • 成長要素
    • 阻礙因素與課題
  • 成長性分析
    • 各產品
    • 各用途
    • 各治療領域
    • 各殺菌法
    • 各流通管道
  • 法規情形
    • 美國
    • 歐洲
    • 澳洲
  • 償付制度
    • 美國
    • 歐洲
    • 澳洲
  • 調劑藥的成本分析
  • 創新的調劑技術
    • Web為基礎的品管系統
    • 數位工具
  • 處方者的洞察
  • 波特的五力分析
  • 競爭情形
    • 商務概要
    • 策略儀表板
  • PESTEL分析

第4章 全球調劑藥局市場:各產品

  • 市場佔有率:各產品(成果值、預測值)
  • 內服藥物
    • 固態
    • 液體
  • 外用藥
    • 軟膏
    • 奶油
    • 凝膠
    • 粘貼
    • 其他
  • 直腸內藥
  • 非口服藥
  • 吸入器
  • 眼科

第5章 全球調劑藥局市場:各用途

  • 市場佔有率:各用途(成果值、預測值)
  • 兒童
  • 成人
  • 老年人
  • 動物

第6章 全球調劑藥局市場:各治療領域

  • 市場佔有率:各治療領域(成果值、預測值)
  • 荷爾蒙補充
  • 疼痛管理
  • 皮膚科
  • 特殊醫藥品
  • 營養補充品
  • 其他

第7章 全球調劑藥局市場:各殺菌類型

  • 市場佔有率:各殺菌類型(成果值、預測值)
  • 無菌
  • 非殺菌

第8章 全球調劑藥局市場:各流通管道

  • 市場佔有率:各流通管道(成果值、預測值)
  • 醫院藥局
  • 調劑藥局
  • 其他

第9章 全球調劑藥局市場:各地區

  • 市場佔有率:各地區(成果值、預測值)
  • 北美
    • 市場規模:各國家、市場區隔(成果值、預測值)
    • 美國
    • 加拿大
  • 歐洲
    • 市場規模:各國家、市場區隔(成果值、預測值)
    • 德國
    • 英國
    • 義大利
    • 西班牙
    • 法國
    • 波蘭
    • 烏克蘭
    • 希臘
    • 瑞典
    • 挪威
    • 比利時
    • 捷克
    • 芬蘭
    • 俄羅斯
  • 亞太地區
    • 市場規模:各國家、市場區隔(成果值、預測值)
    • 中國
    • 印度
    • 日本
    • 新加坡
    • 澳洲
  • 南美
    • 市場規模:各國家、市場區隔(成果值、預測值)
    • 阿根廷
    • 巴西
    • 墨西哥
  • 中東、非洲
    • 市場規模:各國家、市場區隔(成果值、預測值)
    • 南非
    • 阿拉伯聯合大公國
    • 沙烏地阿拉伯
    • 卡達
    • 科威特

第10章 企業簡介

  • B. Braun Medical
  • Doughtery's Pharmacy
  • Fagron
  • Fresenuis Kabi
  • Institutional Pharmacy solutions
  • ITC Compounding Pharmacy
  • Lorraine's Pharmacy
  • Mcguff compounding pharmacy services
  • Pencol Compounding Pharmacy
  • PharmMEDium
  • Rx3 Compounding Pharmacy
  • Triangle compounding Pharmacies
  • Village compounding Pharmacies
  • Wedgewood Village Pharmacy

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 749

Title:
Compounding Pharmacies Market Size By Therapeutic Area (Hormone Replacement, Pain Management, Dermatology Applications, Specialty Drugs, Nutritional Supplements), By Product (Oral, Topical, Rectal, Parenteral, Nasal, Ophthalmic, Otic), By Application (Paediatric, Adult, Geriatric, Veterinary), By Compounding Type (Pharmaceutical Ingredient Alteration [PIA], Currently Unavailable Pharmaceutical Manufacturing [CUPM], Pharmaceutical Dosage Alteration [PDA]), By Sterility (Sterile, Non-sterile), By Distribution Channel (Hospital Pharmacy, Compounding Pharmacy) Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2019 - 2025 .

Compounding Pharmacies market will reach USD 12.5 billion by 2024; as per a new research report.

Rising prevalence of chronic and non-communicable diseases worldwide will drive compounding pharmacy market growth over the forecast timeframe. Growing elderly population suffering from chronic diseases such as diabetes, asthma and other cardiac disorders coupled with increasing life expectancy across the world will propel the industry growth. Furthermore, increasing aesthetic concerns will fuel the demand for anti-ageing products such as testosterone therapy for men, bioidentical hormone replacement therapy for women and other high quality dermatological products that are produced in compounding pharmacies.

Dearth of cancer drugs or other essential drugs in developed region such as Europe and North America will augment the demand for compounding pharmacies over the forthcoming years. Limited supply of raw materials, production delay by manufacturers and discontinuation of commercialized drug has led to drug shortage. Ability of compounding pharmacies to fill a gap by replicating commercial drugs in case of shortage will fuel the demand for compounded medicines thereby propelling industry growth.

However, the continuous changing regulatory norms and standards will impede the market growth to some extent. Furthermore, high cost of equipment, sterility maintenance and lack of skilled lab technicians and pharmacists will hamper the growth of compounding pharmacies market.

Topical segment will show significant growth over the forecast period owing to the rising prevalence of diabetes worldwide. Growing adoption of unhealthy dietary habits and rising prevalence of obesity are the key factors increasing prevalence of diabetes among the people that subsequently lead to increase in demand of compounded long acting and rapid acting insulin analogs. Moreover, availability of other compounded topical preparations of antidiabetic drugs such as DPP-4 inhibitors and GLP-1 agonists will further witness a significant growth in the future owing to its application in treatment of type II diabetes.

Pediatric segment is estimated to grow at a considerable rate over forecast period owing to growing awareness pertaining to compounding pharmacies and increasing infant morbidity and mortality. Furthermore, customization of medicines to formulate convenient dosage forms for children such as conversion of big, solid pills into easy-to-administer liquid dosage form, will significantly boost the segment growth during analysis period.

Hormone replacement segment will grow at a faster rate during the forecast period due to increasing demand for various anti-ageing products as well hormone replacement theories among adults. Increasing focus of people on excellent quality dermatological products that are compounded as per the patients needs and requirements will further escalate hormone replacement segment growth.

U.S. compounding pharmacies market dominated the industry owing to the presence of geriatric patient pool, developed healthcare facilities and technological advancements. U.S. pharmaceutical industry has witnessed several incidences of drug shortage over the past few years. Increasing drug shortage will certainly boost demand for compounded medications.

Some of the notable industry players are Fagron, B. Braun, Fresenius Kabi, Cantrell Drug Company, McGuff, PharMEDium, Institutional Pharmacy Solutions, Triangle Compounding Pharmacies, Village Compounding Pharmacy, Pencol Compounding Pharmacy and Wedgewood Village Pharmacy. Major industry players are emphasizing on enhancing and strengthening the product portfolio. They are further focusing on partnerships and collaborations to enhance their existing systems.

Table of Contents

Chapter 1. Methodology

  • 1.1. Methodology
    • 1.1.1. Initial data exploration
    • 1.1.2. Statistical model and forecast
    • 1.1.3. Industry insights and validation
    • 1.1.4. Market definition and forecast parameters
  • 1.2. Data sources
    • 1.2.1. Secondary
    • 1.2.2. Primary

Chapter 2. Executive Summary

  • 2.1. Compounding pharmacies industry 360 degree synopsis, 2014 - 2025
    • 2.1.1. Business trends
    • 2.1.2. Product trends
    • 2.1.3. Application trends
    • 2.1.4. Therapeutic area trends
    • 2.1.5. Distribution channel trends
    • 2.1.6. Sterility type trends
    • 2.1.7. Regional trends

Chapter 3. Compounding Pharmacies Industry Insights

  • 3.1. Industry segmentation
  • 3.2. Industry size and forecast, 2014 - 2025
  • 3.3. Industry ecosystem analysis
    • 3.3.1. Vendor matrix
    • 3.3.2. Distribution channel analysis
  • 3.4. Industry impact forces
    • 3.4.1. Growth drivers
      • 3.4.1.1. Increasing geriatric population & longevity globally
      • 3.4.1.2. Growing acceptance of personalized medicines worldwide in U.S. and Europe
      • 3.4.1.3. Increasing drug shortage in North America and Europe
      • 3.4.1.4. Convenience of using compounded drugs
      • 3.4.1.5. Growing drug failure rate
    • 3.4.2. Industry pitfalls & challenges
      • 3.4.2.1. Lack of skilled lab technicians and pharmacists in developed countries
      • 3.4.2.2. High costs of equipment and maintenance of sterile environment
      • 3.4.2.3. Changing regulatory specifications
      • 3.4.2.4. Consumers perception towards compounded drugs
  • 3.5. Growth potential analysis
    • 3.5.1. By product
    • 3.5.2. By application
    • 3.5.3. By therapeutic area
    • 3.5.4. By sterility
    • 3.5.5. By distribution channel
  • 3.6. Regulatory landscape
    • 3.6.1. U.S
    • 3.6.2. Europe
    • 3.6.3. Australia
  • 3.7. Reimbursement landscape
    • 3.7.1. U.S.
    • 3.7.2. Europe
    • 3.7.3. Australia
  • 3.8. Cost analysis of compounded medications
  • 3.9. Compounding pharmacies count, by region 2018
    • 3.9.1. North America
    • 3.9.2. Europe
    • 3.9.3. Asia Pacific
    • 3.9.4. Latin America
    • 3.9.5. Middle East and Africa
  • 3.10. Innovative compounding technologies
    • 3.10.1. Web-based quality management system
    • 3.10.2. Digital tools
  • 3.11. Prescriber insights
  • 3.12. Porter's analysis
  • 3.13. Competitive landscape, 2018
    • 3.13.1. Business overview
    • 3.13.2. Strategy dashboard
  • 3.14. PESTEL analysis

Chapter 4. Compounding Pharmacies Market, By Product

  • 4.1. Compounding pharmacies market share, by product, 2018 & 2025
  • 4.2. Oral
    • 4.2.1. Market size, by region, 2014 - 2025
    • 4.2.2. Solid preparations
      • 4.2.2.1. Market size, by region, 2014 - 2025
      • 4.2.2.2. Tablets
        • 4.2.2.2.1. Market size, by region, 2014 - 2025
      • 4.2.2.3. Capsules
        • 4.2.2.3.1. Market size, by region, 2014 - 2025
      • 4.2.2.4. Granules
        • 4.2.2.4.1. Market size, by region, 2014 - 2025
      • 4.2.2.5. Powder
        • 4.2.2.5.1. Market size, by region, 2014 - 2025
      • 4.2.2.6. Others
        • 4.2.2.6.1. Market size, by region, 2014 - 2025
    • 4.2.3. Liquid preparations
      • 4.2.3.1. Market size, by region, 2014 - 2025
      • 4.2.3.2. Solutions
        • 4.2.3.2.1. Market size, by region, 2014 - 2025
      • 4.2.3.3. Suspension
        • 4.2.3.3.1. Market size, by region, 2014 - 2025
      • 4.2.3.4. Emulsion
        • 4.2.3.4.1. Market size, by region, 2014 - 2025
      • 4.2.3.5. Syrup
        • 4.2.3.5.1. Market size, by region, 2014 - 2025
      • 4.2.3.6. Others
        • 4.2.3.6.1. Market size, by region, 2014 - 2025
  • 4.3. Topical
    • 4.3.1. Market size, by region, 2014 - 2025
    • 4.3.2. Ointments
      • 4.3.2.1. Market size, by region, 2014 - 2025
    • 4.3.3. Creams
      • 4.3.3.1. Market size, by region, 2014 - 2025
    • 4.3.4. Gels
      • 4.3.4.1. Market size, by region, 2014 - 2025
    • 4.3.5. Pastes
      • 4.3.5.1. Market size, by region, 2014 - 2025
    • 4.3.6. Others
      • 4.3.6.1. Market size, by region, 2014 - 2025
  • 4.4. Rectal
    • 4.4.1. Market size, by region, 2014 - 2025
    • 4.4.2. Suppositories
      • 4.4.2.1. Market size, by region, 2014 - 2025
    • 4.4.3. Enema
      • 4.4.3.1. Market size, by region, 2014 - 2025
    • 4.4.4. Others
      • 4.4.4.1. Market size, by region, 2014 - 2025
  • 4.5. Parenteral
    • 4.5.1. Market size, by region, 2014 - 2025
  • 4.6. Inhaler
    • 4.6.1. Market size, by region, 2014 - 2025
  • 4.7. Ophthalmic
    • 4.7.1. Market size, by region, 2014 - 2025
      • 4.7.1.1. Eye drops
        • 4.7.1.1.1. Market size, by region, 2014 - 2025
      • 4.7.1.2. Ear drops
        • 4.7.1.2.1. Market size, by region, 2014 - 2025
      • 4.7.1.3. Nasal drops
        • 4.7.1.3.1. Market size, by region, 2014 - 2025
      • 4.7.1.4. Others
        • 4.7.1.4.1. Market size, by region, 2014 - 2025

Chapter 5. Compounding Pharmacies Market, By Application

  • 5.1. Compounding Pharmacies market share, by application, 2018 & 2025
  • 5.2. Pediatrics
    • 5.2.1. Market size, by region, 2014 - 2025
  • 5.3. Adult
    • 5.3.1. Market size, by region, 2014 - 2025
  • 5.4. Geriatric
    • 5.4.1. Market size, by region, 2014 - 2025
  • 5.5. Veterinary
    • 5.5.1. Market size, by region, 2014 - 2025

Chapter 6. Compounding Pharmacies Market, By Therapeutic Area

  • 6.1. Compounding pharmacies market share, by therapeutic area, 2018 & 2025
  • 6.2. Hormone Replacement
    • 6.2.1. Market size, by region, 2014 - 2025
  • 6.3. Pain Management
    • 6.3.1. Market size, by region, 2014 - 2025
  • 6.4. Dermatology
    • 6.4.1. Market size, by region, 2014 - 2025
  • 6.5. Specialty drugs
    • 6.5.1. Market size, by region, 2014 - 2025
  • 6.6. Nutritional supplements
    • 6.6.1. Market size, by region, 2014 - 2025
  • 6.7. Others
    • 6.7.1. Market size, by region, 2014 - 2025

Chapter 7. Compounding Pharmacies Market, By Sterility

  • 7.1. Compounding pharmacies market share, by sterility, 2018 & 2025
  • 7.2. Sterile
    • 7.2.1. Market size, by region, 2014 - 2025
  • 7.3. Non-sterile
    • 7.3.1. Market size, by region, 2014 - 2025

Chapter 8. Compounding Pharmacies Market, By Distribution Channel

  • 8.1. Compounding pharmacies market share, by distribution channel, 2018 & 2025
  • 8.2. Hospital pharmacies
    • 8.2.1. Market size, by region, 2014 - 2025
  • 8.3. Compounding pharmacies
    • 8.3.1. Market size, by region, 2014 - 2025
  • 8.4. Others
    • 8.4.1. Market size, by region, 2014 - 2025

Chapter 9. Compounding Pharmacies Market, By Region

  • 9.1. Compounding pharmacies Market share, by region, 2018 & 2025
  • 9.2. North America
    • 9.2.1. Market size, by country, 2014 - 2025
    • 9.2.2. Market size, by product, 2014 - 2025
      • 9.2.2.1. Market size, by oral, 2014 - 2025
        • 9.2.2.1.1. Market size, by solid preparations, 2014 - 2025
        • 9.2.2.1.2. Market size, by liquid preparations, 2014 - 2025
      • 9.2.2.2. Market size, by topical, 2014 - 2025
      • 9.2.2.3. Market size, by rectal, 2014 - 2025
      • 9.2.2.4. Market size, by parenteral, 2014 - 2025
    • 9.2.3. Market size, by application, 2014 - 2025
    • 9.2.4. Market size, by therapeutic area, 2014 - 2025
    • 9.2.5. Market size, by sterility, 2014 - 2025
    • 9.2.6. Market size, by distribution channel, 2014 - 2025
    • 9.2.7. U.S.
      • 9.2.7.1. Market size, by product, 2014 - 2025
        • 9.2.7.1.1. Market size, by oral, 2014 - 2025
        • 9.2.7.1.1.1. Market size, by solid preparations, 2014 - 2025
        • 9.2.7.1.1.2. Market size, by liquid preparations, 2014 - 2025
        • 9.2.7.1.2. Market size, by topical, 2014 - 2025
        • 9.2.7.1.3. Market size, by rectal, 2014 - 2025
        • 9.2.7.1.4. Market size, by parenteral, 2014 - 2025
      • 9.2.7.2. Market size, by application, 2014 - 2025
      • 9.2.7.3. Market size, by therapeutic area, 2014 - 2025
      • 9.2.7.4. Market size, by sterility, 2014 - 2025
      • 9.2.7.5. Market size, by distribution channel, 2014 - 2025
    • 9.2.8. Canada
      • 9.2.8.1. Market size, by product, 2014 - 2025
        • 9.2.8.1.1. Market size, by oral, 2014 - 2025
        • 9.2.8.1.1.1. Market size, by solid preparations, 2014 - 2025
        • 9.2.8.1.1.2. Market size, by liquid preparations, 2014 - 2025
        • 9.2.8.1.2. Market size, by topical, 2014 - 2025
        • 9.2.8.1.3. Market size, by rectal, 2014 - 2025
        • 9.2.8.1.4. Market size, by parenteral, 2014 - 2025
      • 9.2.8.2. Market size, by application, 2014 - 2025
      • 9.2.8.3. Market size, by therapeutic area, 2014 - 2025
      • 9.2.8.4. Market size, by sterility, 2014 - 2025
      • 9.2.8.5. Market size, by distribution channel, 2014 - 2025
  • 9.3. Europe
    • 9.3.1. Market size, by country, 2014 - 2025
    • 9.3.2. Market size, by product, 2014 - 2025
      • 9.3.2.1. Market size, by oral, 2014 - 2025
        • 9.3.2.1.1. Market size, by solid preparations, 2014 - 2025
        • 9.3.2.1.2. Market size, by liquid preparations, 2014 - 2025
      • 9.3.2.2. Market size, by topical, 2014 - 2025
      • 9.3.2.3. Market size, by rectal, 2014 - 2025
    • 9.3.3. Market size, by parenteral, 2014 - 2025
    • 9.3.4. Germany
      • 9.3.4.1. Market size, by product, 2014 - 2025
        • 9.3.4.1.1. Market size, by oral, 2014 - 2025
        • 9.3.4.1.1.1. Market size, by solid preparations, 2014 - 2025
        • 9.3.4.1.1.2. Market size, by liquid preparations, 2014 - 2025
        • 9.3.4.1.2. Market size, by topical, 2014 - 2025
        • 9.3.4.1.3. Market size, by rectal, 2014 - 2025
        • 9.3.4.1.4. Market size, by parenteral, 2014 - 2025
      • 9.3.4.2. Market size, by application, 2014 - 2025
      • 9.3.4.3. Market size, by therapeutic area, 2014 - 2025
      • 9.3.4.4. Market size, by sterility, 2014 - 2025
      • 9.3.4.5. Market size, by distribution channel, 2014 - 2025
    • 9.3.5. UK
      • 9.3.5.1. Market size, by product, 2014 - 2025
        • 9.3.5.1.1. Market size, by oral, 2014 - 2025
        • 9.3.5.1.1.1. Market size, by solid preparations, 2014 - 2025
        • 9.3.5.1.1.2. Market size, by liquid preparations, 2014 - 2025
        • 9.3.5.1.2. Market size, by topical, 2014 - 2025
        • 9.3.5.1.3. Market size, by rectal, 2014 - 2025
        • 9.3.5.1.4. Market size, by parenteral, 2014 - 2025
      • 9.3.5.2. Market size, by application, 2014 - 2025
      • 9.3.5.3. Market size, by therapeutic area, 2014 - 2025
      • 9.3.5.4. Market size, by sterility, 2014 - 2025
      • 9.3.5.5. Market size, by distribution channel, 2014 - 2025
    • 9.3.6. Italy
      • 9.3.6.1. Market size, by product, 2014 - 2025
        • 9.3.6.1.1. Market size, by oral, 2014 - 2025
        • 9.3.6.1.1.1. Market size, by solid preparations, 2014 - 2025
        • 9.3.6.1.1.2. Market size, by liquid preparations, 2014 - 2025
        • 9.3.6.1.2. Market size, by topical, 2014 - 2025
        • 9.3.6.1.3. Market size, by rectal, 2014 - 2025
        • 9.3.6.1.4. Market size, by parenteral, 2014 - 2025
      • 9.3.6.2. Market size, by application, 2014 - 2025
      • 9.3.6.3. Market size, by therapeutic area, 2014 - 2025
      • 9.3.6.4. Market size, by sterility, 2014 - 2025
      • 9.3.6.5. Market size, by distribution channel, 2014 - 2025
    • 9.3.7. Spain
      • 9.3.7.1. Market size, by product, 2014 - 2025
        • 9.3.7.1.1. Market size, by oral, 2014 - 2025
        • 9.3.7.1.1.1. Market size, by solid preparations, 2014 - 2025
        • 9.3.7.1.1.2. Market size, by liquid preparations, 2014 - 2025
        • 9.3.7.1.2. Market size, by topical, 2014 - 2025
        • 9.3.7.1.3. Market size, by rectal, 2014 - 2025
        • 9.3.7.1.4. Market size, by parenteral, 2014 - 2025
      • 9.3.7.2. Market size, by application, 2014 - 2025
      • 9.3.7.3. Market size, by therapeutic area, 2014 - 2025
      • 9.3.7.4. Market size, by sterility, 2014 - 2025
      • 9.3.7.5. Market size, by distribution channel, 2014 - 2025
    • 9.3.8. France
      • 9.3.8.1. Market size, by product, 2014 - 2025
        • 9.3.8.1.1. Market size, by oral, 2014 - 2025
        • 9.3.8.1.1.1. Market size, by solid preparations, 2014 - 2025
        • 9.3.8.1.1.2. Market size, by liquid preparations, 2014 - 2025
        • 9.3.8.1.2. Market size, by topical, 2014 - 2025
        • 9.3.8.1.3. Market size, by rectal, 2014 - 2025
        • 9.3.8.1.4. Market size, by parenteral, 2014 - 2025
      • 9.3.8.2. Market size, by application, 2014 - 2025
      • 9.3.8.3. Market size, by therapeutic area, 2014 - 2025
      • 9.3.8.4. Market size, by sterility, 2014 - 2025
      • 9.3.8.5. Market size, by distribution channel, 2014 - 2025
    • 9.3.9. Poland
      • 9.3.9.1. Market size, by product, 2014 - 2025
        • 9.3.9.1.1. Market size, by oral, 2014 - 2025
        • 9.3.9.1.1.1. Market size, by solid preparations, 2014 - 2025
        • 9.3.9.1.1.2. Market size, by liquid preparations, 2014 - 2025
        • 9.3.9.1.2. Market size, by topical, 2014 - 2025
        • 9.3.9.1.3. Market size, by rectal, 2014 - 2025
        • 9.3.9.1.4. Market size, by parenteral, 2014 - 2025
      • 9.3.9.2. Market size, by application, 2014 - 2025
      • 9.3.9.3. Market size, by therapeutic area, 2014 - 2025
      • 9.3.9.4. Market size, by sterility, 2014 - 2025
      • 9.3.9.5. Market size, by distribution channel, 2014 - 2025
    • 9.3.10. Ukraine
      • 9.3.10.1. Market size, by product, 2014 - 2025
        • 9.3.10.1.1. Market size, by oral, 2014 - 2025
        • 9.3.10.1.1.1. Market size, by solid preparations, 2014 - 2025
        • 9.3.10.1.1.2. Market size, by liquid preparations, 2014 - 2025
        • 9.3.10.1.2. Market size, by topical, 2014 - 2025
        • 9.3.10.1.3. Market size, by rectal, 2014 - 2025
        • 9.3.10.1.4. Market size, by parenteral, 2014 - 2025
      • 9.3.10.2. Market size, by application, 2014 - 2025
      • 9.3.10.3. Market size, by therapeutic area, 2014 - 2025
      • 9.3.10.4. Market size, by sterility, 2014 - 2025
      • 9.3.10.5. Market size, by distribution channel, 2014 - 2025
    • 9.3.11. Greece
      • 9.3.11.1. Market size, by product, 2014 - 2025
        • 9.3.11.1.1. Market size, by oral, 2014 - 2025
        • 9.3.11.1.1.1. Market size, by solid preparations, 2014 - 2025
        • 9.3.11.1.1.2. Market size, by liquid preparations, 2014 - 2025
        • 9.3.11.1.2. Market size, by topical, 2014 - 2025
        • 9.3.11.1.3. Market size, by rectal, 2014 - 2025
        • 9.3.11.1.4. Market size, by parenteral, 2014 - 2025
      • 9.3.11.2. Market size, by application, 2014 - 2025
      • 9.3.11.3. Market size, by therapeutic area, 2014 - 2025
      • 9.3.11.4. Market size, by sterility, 2014 - 2025
      • 9.3.11.5. Market size, by distribution channel, 2014 - 2025
    • 9.3.12. Sweden
      • 9.3.12.1. Market size, by product, 2014 - 2025
        • 9.3.12.1.1. Market size, by oral, 2014 - 2025
        • 9.3.12.1.1.1. Market size, by solid preparations, 2014 - 2025
        • 9.3.12.1.1.2. Market size, by liquid preparations, 2014 - 2025
        • 9.3.12.1.2. Market size, by topical, 2014 - 2025
        • 9.3.12.1.3. Market size, by rectal, 2014 - 2025
        • 9.3.12.1.4. Market size, by parenteral, 2014 - 2025
      • 9.3.12.2. Market size, by application, 2014 - 2025
      • 9.3.12.3. Market size, by therapeutic area, 2014 - 2025
      • 9.3.12.4. Market size, by sterility, 2014 - 2025
      • 9.3.12.5. Market size, by distribution channel, 2014 - 2025
    • 9.3.13. Norway
      • 9.3.13.1. Market size, by product, 2014 - 2025
        • 9.3.13.1.1. Market size, by oral, 2014 - 2025
        • 9.3.13.1.1.1. Market size, by solid preparations, 2014 - 2025
        • 9.3.13.1.1.2. Market size, by liquid preparations, 2014 - 2025
        • 9.3.13.1.2. Market size, by topical, 2014 - 2025
        • 9.3.13.1.3. Market size, by rectal, 2014 - 2025
        • 9.3.13.1.4. Market size, by parenteral, 2014 - 2025
      • 9.3.13.2. Market size, by application, 2014 - 2025
      • 9.3.13.3. Market size, by therapeutic area, 2014 - 2025
      • 9.3.13.4. Market size, by sterility, 2014 - 2025
      • 9.3.13.5. Market size, by distribution channel, 2014 - 2025
    • 9.3.14. Belgium
      • 9.3.14.1. Market size, by product, 2014 - 2025
        • 9.3.14.1.1. Market size, by oral, 2014 - 2025
        • 9.3.14.1.1.1. Market size, by solid preparations, 2014 - 2025
        • 9.3.14.1.1.2. Market size, by liquid preparations, 2014 - 2025
        • 9.3.14.1.2. Market size, by topical, 2014 - 2025
        • 9.3.14.1.3. Market size, by rectal, 2014 - 2025
        • 9.3.14.1.4. Market size, by parenteral, 2014 - 2025
      • 9.3.14.2. Market size, by application, 2014 - 2025
      • 9.3.14.3. Market size, by therapeutic area, 2014 - 2025
      • 9.3.14.4. Market size, by sterility, 2014 - 2025
      • 9.3.14.5. Market size, by distribution channel, 2014 - 2025
    • 9.3.15. Czech Republic
      • 9.3.15.1. Market size, by product, 2014 - 2025
        • 9.3.15.1.1. Market size, by oral, 2014 - 2025
        • 9.3.15.1.1.1. Market size, by solid preparations, 2014 - 2025
        • 9.3.15.1.1.2. Market size, by liquid preparations, 2014 - 2025
        • 9.3.15.1.2. Market size, by topical, 2014 - 2025
        • 9.3.15.1.3. Market size, by rectal, 2014 - 2025
        • 9.3.15.1.4. Market size, by parenteral, 2014 - 2025
      • 9.3.15.2. Market size, by application, 2014 - 2025
      • 9.3.15.3. Market size, by therapeutic area, 2014 - 2025
      • 9.3.15.4. Market size, by sterility, 2014 - 2025
      • 9.3.15.5. Market size, by distribution channel, 2014 - 2025
    • 9.3.16. Finland
      • 9.3.16.1. Market size, by product, 2014 - 2025
        • 9.3.16.1.1. Market size, by oral, 2014 - 2025
        • 9.3.16.1.1.1. Market size, by solid preparations, 2014 - 2025
        • 9.3.16.1.1.2. Market size, by liquid preparations, 2014 - 2025
        • 9.3.16.1.2. Market size, by topical, 2014 - 2025
        • 9.3.16.1.3. Market size, by rectal, 2014 - 2025
        • 9.3.16.1.4. Market size, by parenteral, 2014 - 2025
      • 9.3.16.2. Market size, by application, 2014 - 2025
      • 9.3.16.3. Market size, by therapeutic area, 2014 - 2025
      • 9.3.16.4. Market size, by sterility, 2014 - 2025
      • 9.3.16.5. Market size, by distribution channel, 2014 - 2025
    • 9.3.17. Russia
      • 9.3.17.1. Market size, by product, 2014 - 2025
        • 9.3.17.1.1. Market size, by oral, 2014 - 2025
        • 9.3.17.1.1.1. Market size, by solid preparations, 2014 - 2025
        • 9.3.17.1.1.2. Market size, by liquid preparations, 2014 - 2025
        • 9.3.17.1.2. Market size, by topical, 2014 - 2025
        • 9.3.17.1.3. Market size, by rectal, 2014 - 2025
        • 9.3.17.1.4. Market size, by parenteral, 2014 - 2025
      • 9.3.17.2. Market size, by application, 2014 - 2025
      • 9.3.17.3. Market size, by therapeutic area, 2014 - 2025
      • 9.3.17.4. Market size, by sterility, 2014 - 2025
      • 9.3.17.5. Market size, by distribution channel, 2014 - 2025
  • 9.4. Asia Pacific
    • 9.4.1. Market size, by country, 2014 - 2025
    • 9.4.2. Market size, by product, 2014 - 2025
      • 9.4.2.1. Market size, by oral, 2014 - 2025
        • 9.4.2.1.1. Market size, by solid preparations, 2014 - 2025
        • 9.4.2.1.2. Market size, by liquid preparations, 2014 - 2025
      • 9.4.2.2. Market size, by topical, 2014 - 2025
      • 9.4.2.3. Market size, by rectal, 2014 - 2025
    • 9.4.3. Market size, by parenteral, 2014 - 2025
    • 9.4.4. China
      • 9.4.4.1. Market size, by product, 2014 - 2025
        • 9.4.4.1.1. Market size, by oral, 2014 - 2025
        • 9.4.4.1.1.1. Market size, by solid preparations, 2014 - 2025
        • 9.4.4.1.1.2. Market size, by liquid preparations, 2014 - 2025
        • 9.4.4.1.2. Market size, by topical, 2014 - 2025
        • 9.4.4.1.3. Market size, by rectal, 2014 - 2025
        • 9.4.4.1.4. Market size, by parenteral, 2014 - 2025
      • 9.4.4.2. Market size, by application, 2014 - 2025
      • 9.4.4.3. Market size, by therapeutic area, 2014 - 2025
      • 9.4.4.4. Market size, by sterility, 2014 - 2025
      • 9.4.4.5. Market size, by distribution channel, 2014 - 2025
    • 9.4.5. India
      • 9.4.5.1. Market size, by product, 2014 - 2025
        • 9.4.5.1.1. Market size, by oral, 2014 - 2025
        • 9.4.5.1.1.1. Market size, by solid preparations, 2014 - 2025
        • 9.4.5.1.1.2. Market size, by liquid preparations, 2014 - 2025
        • 9.4.5.1.2. Market size, by topical, 2014 - 2025
        • 9.4.5.1.3. Market size, by rectal, 2014 - 2025
        • 9.4.5.1.4. Market size, by parenteral, 2014 - 2025
      • 9.4.5.2. Market size, by application, 2014 - 2025
      • 9.4.5.3. Market size, by therapeutic area, 2014 - 2025
      • 9.4.5.4. Market size, by sterility, 2014 - 2025
      • 9.4.5.5. Market size, by distribution channel, 2014 - 2025
    • 9.4.6. Japan
      • 9.4.6.1. Market size, by product, 2014 - 2025
        • 9.4.6.1.1. Market size, by oral, 2014 - 2025
        • 9.4.6.1.1.1. Market size, by solid preparations, 2014 - 2025
        • 9.4.6.1.1.2. Market size, by liquid preparations, 2014 - 2025
        • 9.4.6.1.2. Market size, by topical, 2014 - 2025
        • 9.4.6.1.3. Market size, by rectal, 2014 - 2025
        • 9.4.6.1.4. Market size, by parenteral, 2014 - 2025
      • 9.4.6.2. Market size, by application, 2014 - 2025
      • 9.4.6.3. Market size, by therapeutic area, 2014 - 2025
      • 9.4.6.4. Market size, by sterility, 2014 - 2025
      • 9.4.6.5. Market size, by distribution channel, 2014 - 2025
    • 9.4.7. Singapore
      • 9.4.7.1. Market size, by product, 2014 - 2025
        • 9.4.7.1.1. Market size, by oral, 2014 - 2025
        • 9.4.7.1.1.1. Market size, by solid preparations, 2014 - 2025
        • 9.4.7.1.1.2. Market size, by liquid preparations, 2014 - 2025
        • 9.4.7.1.2. Market size, by topical, 2014 - 2025
        • 9.4.7.1.3. Market size, by rectal, 2014 - 2025
        • 9.4.7.1.4. Market size, by parenteral, 2014 - 2025
      • 9.4.7.2. Market size, by application, 2014 - 2025
      • 9.4.7.3. Market size, by therapeutic area, 2014 - 2025
      • 9.4.7.4. Market size, by sterility, 2014 - 2025
      • 9.4.7.5. Market size, by distribution channel, 2014 - 2025
    • 9.4.8. Australia
      • 9.4.8.1. Market size, by product, 2014 - 2025
        • 9.4.8.1.1. Market size, by oral, 2014 - 2025
        • 9.4.8.1.1.1. Market size, by solid preparations, 2014 - 2025
        • 9.4.8.1.1.2. Market size, by liquid preparations, 2014 - 2025
        • 9.4.8.1.2. Market size, by topical, 2014 - 2025
        • 9.4.8.1.3. Market size, by rectal, 2014 - 2025
        • 9.4.8.1.4. Market size, by parenteral, 2014 - 2025
      • 9.4.8.2. Market size, by application, 2014 - 2025
      • 9.4.8.3. Market size, by therapeutic area, 2014 - 2025
      • 9.4.8.4. Market size, by sterility, 2014 - 2025
      • 9.4.8.5. Market size, by distribution channel, 2014 - 2025
  • 9.5. Latin America
    • 9.5.1. Market size, by country, 2014 - 2025
    • 9.5.2. Market size, by product, 2014 - 2025
      • 9.5.2.1. Market size, by oral, 2014 - 2025
        • 9.5.2.1.1. Market size, by solid preparations, 2014 - 2025
        • 9.5.2.1.2. Market size, by liquid preparations, 2014 - 2025
      • 9.5.2.2. Market size, by topical, 2014 - 2025
      • 9.5.2.3. Market size, by rectal, 2014 - 2025
    • 9.5.3. Market size, by parenteral, 2014 - 2025
    • 9.5.4. Argentina
      • 9.5.4.1. Market size, by product, 2014 - 2025
        • 9.5.4.1.1. Market size, by oral, 2014 - 2025
        • 9.5.4.1.1.1. Market size, by solid preparations, 2014 - 2025
        • 9.5.4.1.1.2. Market size, by liquid preparations, 2014 - 2025
        • 9.5.4.1.2. Market size, by topical, 2014 - 2025
        • 9.5.4.1.3. Market size, by rectal, 2014 - 2025
        • 9.5.4.1.4. Market size, by parenteral, 2014 - 2025
      • 9.5.4.2. Market size, by application, 2014 - 2025
      • 9.5.4.3. Market size, by therapeutic area, 2014 - 2025
      • 9.5.4.4. Market size, by sterility, 2014 - 2025
      • 9.5.4.5. Market size, by distribution channel, 2014 - 2025
    • 9.5.5. Brazil
      • 9.5.5.1. Market size, by product, 2014 - 2025
        • 9.5.5.1.1. Market size, by oral, 2014 - 2025
        • 9.5.5.1.1.1. Market size, by solid preparations, 2014 - 2025
        • 9.5.5.1.1.2. Market size, by liquid preparations, 2014 - 2025
        • 9.5.5.1.2. Market size, by topical, 2014 - 2025
        • 9.5.5.1.3. Market size, by rectal, 2014 - 2025
        • 9.5.5.1.4. Market size, by parenteral, 2014 - 2025
      • 9.5.5.2. Market size, by application, 2014 - 2025
      • 9.5.5.3. Market size, by therapeutic area, 2014 - 2025
      • 9.5.5.4. Market size, by sterility, 2014 - 2025
      • 9.5.5.5. Market size, by distribution channel, 2014 - 2025
    • 9.5.6. Mexico
      • 9.5.6.1. Market size, by product, 2014 - 2025
        • 9.5.6.1.1. size, by Market size, by oral, 2014 - 2025
        • 9.5.6.1.1.1. Market solid preparations, 2014 - 2025
        • 9.5.6.1.1.2. Market size, by liquid preparations, 2014 - 2025
        • 9.5.6.1.2. Market size, by topical, 2014 - 2025
        • 9.5.6.1.3. Market size, by rectal, 2014 - 2025
        • 9.5.6.1.4. Market size, by parenteral, 2014 - 2025
      • 9.5.6.2. Market size, by application, 2014 - 2025
      • 9.5.6.3. Market size, by therapeutic area, 2014 - 2025
      • 9.5.6.4. Market size, by sterility, 2014 - 2025
      • 9.5.6.5. Market size, by distribution channel, 2014 - 2025
  • 9.6. Middle East & Africa
    • 9.6.1. Market size, by country, 2014 - 2025
    • 9.6.2. Market size, by product, 2014 - 2025
      • 9.6.2.1. Market size, by oral, 2014 - 2025
        • 9.6.2.1.1. Market size, by solid preparations, 2014 - 2025
        • 9.6.2.1.2. Market size, by liquid preparations, 2014 - 2025
      • 9.6.2.2. Market size, by topical, 2014 - 2025
      • 9.6.2.3. Market size, by rectal, 2014 - 2025
    • 9.6.3. Market size, by parenteral, 2014 - 2025
    • 9.6.4. South Africa
      • 9.6.4.1. Market size, by product, 2014 - 2025
        • 9.6.4.1.1. Market size, by oral, 2014 - 2025
        • 9.6.4.1.1.1. Market size, by solid preparations, 2014 - 2025
        • 9.6.4.1.1.2. Market size, by liquid preparations, 2014 - 2025
        • 9.6.4.1.2. Market size, by topical, 2014 - 2025
        • 9.6.4.1.3. Market size, by rectal, 2014 - 2025
        • 9.6.4.1.4. Market size, by parenteral, 2014 - 2025
      • 9.6.4.2. Market size, by application, 2014 - 2025
      • 9.6.4.3. Market size, by therapeutic area, 2014 - 2025
      • 9.6.4.4. Market size, by sterility, 2014 - 2025
      • 9.6.4.5. Market size, by distribution channel, 2014 - 2025
    • 9.6.5. UAE
      • 9.6.5.1. Market size, by product, 2014 - 2025
        • 9.6.5.1.1. Market size, by oral, 2014 - 2025
        • 9.6.5.1.1.1. Market size, by solid preparations, 2014 - 2025
        • 9.6.5.1.1.2. Market size, by liquid preparations, 2014 - 2025
        • 9.6.5.1.2. Market size, by topical, 2014 - 2025
        • 9.6.5.1.3. Market size, by rectal, 2014 - 2025
        • 9.6.5.1.4. Market size, by parenteral, 2014 - 2025
      • 9.6.5.2. Market size, by application, 2014 - 2025
      • 9.6.5.3. Market size, by therapeutic area, 2014 - 2025
      • 9.6.5.4. Market size, by sterility, 2014 - 2025
      • 9.6.5.5. Market size, by distribution channel, 2014 - 2025
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Market size, by product, 2014 - 2025
        • 9.6.6.1.1. Market size, by oral, 2014 - 2025
        • 9.6.6.1.1.1. Market size, by solid preparations, 2014 - 2025
        • 9.6.6.1.1.2. Market size, by liquid preparations, 2014 - 2025
        • 9.6.6.1.2. Market size, by topical, 2014 - 2025
        • 9.6.6.1.3. Market size, by rectal, 2014 - 2025
        • 9.6.6.1.4. Market size, by parenteral, 2014 - 2025
      • 9.6.6.2. Market size, by application, 2014 - 2025
      • 9.6.6.3. Market size, by therapeutic area, 2014 - 2025
      • 9.6.6.4. Market size, by sterility, 2014 - 2025
      • 9.6.6.5. Market size, by distribution channel, 2014 - 2025
    • 9.6.7. Qatar
      • 9.6.7.1. Market size, by product, 2014 - 2025
        • 9.6.7.1.1. Market size, by oral, 2014 - 2025
        • 9.6.7.1.1.1. Market size, by solid preparations, 2014 - 2025
        • 9.6.7.1.1.2. Market size, by liquid preparations, 2014 - 2025
        • 9.6.7.1.2. Market size, by topical, 2014 - 2025
        • 9.6.7.1.3. Market size, by rectal, 2014 - 2025
        • 9.6.7.1.4. Market size, by parenteral, 2014 - 2025
      • 9.6.7.2. Market size, by application, 2014 - 2025
      • 9.6.7.3. Market size, by therapeutic area, 2014 - 2025
      • 9.6.7.4. Market size, by sterility, 2014 - 2025
      • 9.6.7.5. Market size, by distribution channel, 2014 - 2025
    • 9.6.8. Kuwait
      • 9.6.8.1. Market size, by product, 2014 - 2025
        • 9.6.8.1.1. Market size, by oral, 2014 - 2025
        • 9.6.8.1.1.1. Market size, by solid preparations, 2014 - 2025
        • 9.6.8.1.1.2. Market size, by liquid preparations, 2014 - 2025
        • 9.6.8.1.2. Market size, by topical, 2014 - 2025
        • 9.6.8.1.3. Market size, by rectal, 2014 - 2025
        • 9.6.8.1.4. Market size, by parenteral, 2014 - 2025
      • 9.6.8.2. Market size, by application, 2014 - 2025
      • 9.6.8.3. Market size, by therapeutic area, 2014 - 2025
      • 9.6.8.4. Market size, by sterility, 2014 - 2025
      • 9.6.8.5. Market size, by distribution channel, 2014 - 2025

Chapter 10. Company Profiles

  • 10.1. B. Braun Medical
    • 10.1.1. Business overview
    • 10.1.2. Financial data
    • 10.1.3. Product landscape
    • 10.1.4. Strategic outlook
    • 10.1.5. SWOT analysis
  • 10.2. Doughtery's Pharmacy
    • 10.2.1. Business overview
    • 10.2.2. Financial data
    • 10.2.3. Product landscape
    • 10.2.4. Strategic outlook
    • 10.2.5. SWOT analysis
  • 10.3. Fagron
    • 10.3.1. Business overview
    • 10.3.2. Financial data
    • 10.3.3. Product landscape
    • 10.3.4. Strategic outlook
    • 10.3.5. SWOT analysis
  • 10.4. Fresenuis Kabi
    • 10.4.1. Business overview
    • 10.4.2. Financial data
    • 10.4.3. Product landscape
    • 10.4.4. Strategic outlook
    • 10.4.5. SWOT analysis
  • 10.5. Institutional Pharmacy solutions
    • 10.5.1. Business overview
    • 10.5.2. Financial data
    • 10.5.3. Product landscape
    • 10.5.4. Strategic outlook
    • 10.5.5. SWOT analysis
  • 10.6. ITC Compounding Pharmacy
    • 10.6.1. Business overview
    • 10.6.2. Financial data
    • 10.6.3. Product landscape
    • 10.6.4. Strategic outlook
    • 10.6.5. SWOT analysis
  • 10.7. Lorraine's Pharmacy
    • 10.7.1. Business overview
    • 10.7.2. Financial data
    • 10.7.3. Product landscape
    • 10.7.4. Strategic outlook
    • 10.7.5. SWOT analysis
  • 10.8. Mcguff compounding pharmacy services
    • 10.8.1. Business overview
    • 10.8.2. Financial data
    • 10.8.3. Product landscape
    • 10.8.4. Strategic outlook
    • 10.8.5. SWOT analysis
  • 10.9. Pencol Compounding Pharmacy
    • 10.9.1. Business overview
    • 10.9.2. Financial data
    • 10.9.3. Product landscape
    • 10.9.4. Strategic outlook
    • 10.9.5. SWOT analysis
  • 10.10. PharmMEDium
    • 10.10.1. Business overview
    • 10.10.2. Financial data
    • 10.10.3. Product landscape
    • 10.10.4. Strategic outlook
    • 10.10.5. SWOT analysis
  • 10.11. Rx3 Compounding Pharmacy
    • 10.11.1. Business overview
    • 10.11.2. Financial data
    • 10.11.3. Product landscape
    • 10.11.4. Strategic outlook
    • 10.11.5. SWOT analysis
  • 10.12. Triangle compounding Pharmacies
    • 10.12.1. Business overview
    • 10.12.2. Financial data
    • 10.12.3. Product landscape
    • 10.12.4. Strategic outlook
    • 10.12.5. SWOT analysis
  • 10.13. Village compounding Pharmacies
    • 10.13.1. Business overview
    • 10.13.2. Financial data
    • 10.13.3. Product landscape
    • 10.13.4. Strategic outlook
    • 10.13.5. SWOT analysis
  • 10.14. Wedgewood Village Pharmacy
    • 10.14.1. Business overview
    • 10.14.2. Financial data
    • 10.14.3. Product landscape
    • 10.14.4. Strategic outlook
    • 10.14.5. SWOT analysis

Data Tables

  • TABLE 1. Compounding pharmacies industry 360 degree synopsis, 2014 - 2025
  • TABLE 2. Compounding pharmacies market, 2014 - 2025 (USD Million)
  • TABLE 3. Compounding pharmacies market, by product, 2014 - 2025 (USD Million)
  • TABLE 4. Compounding pharmacies market, by product, 2014 - 2025 (USD Million)
  • TABLE 5. Compounding pharmacies market, by application, 2014 - 2025 (USD Million)
  • TABLE 6. Compounding pharmacies market, by therapeutic area, 2014 - 2025 (USD Million)
  • TABLE 7. Compounding pharmacies market, by sterility, 2014 - 2025 (USD Million)
  • TABLE 8. Compounding pharmacies market, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 9. Compounding pharmacies market, by region, 2014 - 2025 (USD Million)
  • TABLE 10. Industry impact forces
  • TABLE 11. Oral market by region, 2014 - 2025 (USD Million)
  • TABLE 12. Solid preparations market, by region, 2014-2025, (USD Mn)
  • TABLE 13. Tablets market, by region, 2014-2025, (USD Million)
  • TABLE 14. Capsules market, by region, 2014-2025, (USD Million)
  • TABLE 15. Granules market, by region, 2014-2025, (USD Million)
  • TABLE 16. Powder market, by region, 2014-2025, (USD Million)
  • TABLE 17. Others market, by region, 2014-2025, (USD Million)
  • TABLE 18. Liquid preparations market, by region, 2014-2025, (USD Million)
  • TABLE 19. Solutions market, by region, 2014-2025, (USD Million)
  • TABLE 20. Suspension market, by region, 2014-2025, (USD Mn)
  • TABLE 21. Emulsion market, by region, 2014-2025, (USD Million)
  • TABLE 22. Syrup market, by region, 2014-2025, (USD Million)
  • TABLE 23. Others market, by region, 2014-2025, (USD Million)
  • TABLE 24. Topical market, by region, 2014-2025, (USD Million)
  • TABLE 25. Ointments market, by region, 2014-2025, (USD Million)
  • TABLE 26. Creams market, by region, 2014-2025, (USD Million)
  • TABLE 27. Gels market, by region, 2014-2025, (USD Million)
  • TABLE 28. Pastes market, by region, 2014-2025, (USD Million)
  • TABLE 29. Others market, 2014-2025, (USD Million)
  • TABLE 30. Rectal market by region, 2014 - 2025 (USD Million)
  • TABLE 31. Suppositories market, by region, 2014-2025, (USD Mn)
  • TABLE 32. Enema market, by region, 2014-2025, (USD Million)
  • TABLE 33. Others market, by region, 2014-2025, (USD Million)
  • TABLE 34. Parenteral market by region, 2014 - 2025 (USD Million)
  • TABLE 35. Ophthalmic market by region, 2014 - 2025 (USD Million)
  • TABLE 36. Pediatric compounding pharmacies market, by region, 2014-2025, (USD Million)
  • TABLE 37. Adult compounding pharmacies market, by region 2014-2025, (USD Million)
  • TABLE 38. Geriatric compounding pharmacies market, by region 2014-2025, (USD Million)
  • TABLE 39. Veterinary compounding pharmacies market, by region 2014-2025, (USD Million)
  • TABLE 40. Hormone replacement compounding pharmacies market, by region, 2014-2025, (USD Mn)
  • TABLE 41. Sterile compounding pharmacies market, by region, 2014-2025, (USD Mn)
  • TABLE 42. Non-sterile compounding pharmacies market, by region, 2014-2025, (USD Mn)
  • TABLE 43. Hospital compounding pharmacies market, by region, 2014-2025, (USD Mn)
  • TABLE 44. Others market, by region, 2014-2025, (USD Mn)
  • TABLE 45. North America compounding pharmacies market, by country, 2014-2025 (USD Million)
  • TABLE 46. North America compounding pharmacies market, by product, 2014-2025 (USD Million)
  • TABLE 47. North America compounding pharmacies market, by oral, 2014-2025 (USD Million)
  • TABLE 48. North America compounding pharmacies market, by solid preparations, 2014-2025 (USD Million)
  • TABLE 49. North America compounding pharmacies market, by liquid preparations, 2014-2025 (USD Million)
  • TABLE 50. North America compounding pharmacies market, by topical, 2014-2025 (USD Million)
  • TABLE 51. North America compounding pharmacies market, by rectal, 2014-2025 (USD Million)
  • TABLE 52. North America compounding pharmacies market, by parenteral, 2014-2025 (USD Million)
  • TABLE 53. North America compounding pharmacies market, by application, 2014-2025 (USD Mn)
  • TABLE 54. North America compounding pharmacies market, by therapeutic areas, 2014-2025 (USD Million)
  • TABLE 55. North America compounding pharmacies market, by sterility, 2014-2025 (USD Million)
  • TABLE 56. North America compounding pharmacies market, by distribution channel, 2014-2025 (USD Million)
  • TABLE 57. U.S. compounding pharmacies market, by product, 2014-2025 (USD Million)
  • TABLE 58. U.S. compounding pharmacies market, by oral, 2014-2025 (USD Million)
  • TABLE 59. U.S. compounding pharmacies market, by solid preparations, 2014-2025 (USD Million)
  • TABLE 60. U.S. compounding pharmacies market, by liquid preparations, 2014-2025 (USD Million)
  • TABLE 61. U.S. compounding pharmacies market, by topical, 2014-2025 (USD Million)
  • TABLE 62. U.S. compounding pharmacies market, by rectal, 2014-2025 (USD Million)
  • TABLE 63. U.S. compounding pharmacies market, by parenteral, 2014-2025 (USD Million)
  • TABLE 64. U.S. compounding pharmacies market, by application, 2014-2025 (USD Million)
  • TABLE 65. U.S. compounding pharmacies market, by therapeutic areas, 2014-2025 (USD Million)
  • TABLE 66. U.S. compounding pharmacies market, by sterility, 2014-2025 (USD Million)
  • TABLE 67. U.S. compounding pharmacies market, by distribution channel, 2014-2025 (USD Million)
  • TABLE 68. Canada compounding pharmacies market, by product, 2014-2025 (USD Million)
  • TABLE 69. Canada compounding pharmacies market, by product, 2014-2025 (USD Million)
  • TABLE 70. Canada compounding pharmacies market, by oral, 2014-2025 (USD Million)
  • TABLE 71. Canada compounding pharmacies market, by solid preparations, 2014-2025 (USD Million)
  • TABLE 72. Canada compounding pharmacies market, by liquid preparations, 2014-2025 (USD Million)
  • TABLE 73. Canada compounding pharmacies market, by topical, 2014-2025 (USD Million)
  • TABLE 74. Canada compounding pharmacies market, by rectal, 2014-2025 (USD Million)
  • TABLE 75. Canada compounding pharmacies market, by parenteral, 2014-2025 (USD Million)
  • TABLE 76. Canada compounding pharmacies market, by application, 2014-2025 (USD Million)
  • TABLE 77. Canada compounding pharmacies market, by therapeutic areas, 2014-2025 (USD Million)
  • TABLE 78. Canada compounding pharmacies market, by sterility, 2014-2025 (USD Million)
  • TABLE 79. Canada compounding pharmacies market, by distribution channel, 2014-2025 (USD Million)
  • TABLE 80. Europe compounding pharmacies market, by country 2014-2025 (USD Million)
  • TABLE 81. Europe compounding pharmacies market, by product, 2014-2025 (USD Million)
  • TABLE 82. Europe compounding pharmacies market, by application, 2014-2025 (USD Million)
  • TABLE 83. Europe compounding pharmacies market, by therapeutic areas, 2014-2025 (USD Million)
  • TABLE 84. Europe compounding pharmacies market, by sterility, 2014-2025 (USD Million)
  • TABLE 85. Europe compounding pharmacies market, by distribution channel, 2014-2025 (USD Million)
  • TABLE 86. Europe compounding pharmacies market, by product, 2014-2025 (USD Million)
  • TABLE 87. Europe compounding pharmacies market, by oral, 2014-2025 (USD Million)
  • TABLE 88. Europe compounding pharmacies market, by solid preparations, 2014-2025 (USD Million)
  • TABLE 89. Europe compounding pharmacies market, by liquid preparations, 2014-2025 (USD Million)
  • TABLE 90. Europe compounding pharmacies market, by topical, 2014-2025 (USD Million)
  • TABLE 91. Europe compounding pharmacies market, by rectal, 2014-2025 (USD Million)
  • TABLE 92. Europe compounding pharmacies market, by parenteral, 2014-2025 (USD Million)
  • TABLE 93. Germany compounding pharmacies market, by product, 2014-2025 (USD Million)
  • TABLE 94. Germany compounding pharmacies market, by product, 2014-2025 (USD Million)
  • TABLE 95. Germany compounding pharmacies market, by oral, 2014-2025 (USD Million)
  • TABLE 96. Germany compounding pharmacies market, by solid preparations, 2014-2025 (USD Million)
  • TABLE 97. Germany compounding pharmacies market, by liquid preparations, 2014-2025 (USD Million)
  • TABLE 98. Germany compounding pharmacies market, by topical, 2014-2025 (USD Million)
  • TABLE 99. Germany compounding pharmacies market, by rectal, 2014-2025 (USD Million)
  • TABLE 100. Germany compounding pharmacies market, by parenteral, 2014-2025 (USD Million)
  • TABLE 101. Germany compounding pharmacies market, by application, 2014-2025 (USD Million)
  • TABLE 102. Germany compounding pharmacies market, by therapeutic areas, 2014-2025 (USD Million)
  • TABLE 103. Germany compounding pharmacies market, by sterility, 2014-2025 (USD Million)
  • TABLE 104. Germany compounding pharmacies market, by distribution channel, 2014-2025 (USD Million)
  • TABLE 105. UK compounding pharmacies market, by product, 2014-2025 (USD Million)
  • TABLE 106. UK compounding pharmacies market, by application, 2014-2025 (USD Million)
  • TABLE 107. UK compounding pharmacies market, by therapeutic areas, 2014-2025 (USD Million)
  • TABLE 108. UK compounding pharmacies market, by sterility, 2014-2025 (USD Million)
  • TABLE 109. UK compounding pharmacies market, by distribution channel, 2014-2025 (USD Million)
  • TABLE 110. UK compounding pharmacies market, by product, 2014-2025 (USD Million)
  • TABLE 111. UK compounding pharmacies market, by oral, 2014-2025 (USD Million)
  • TABLE 112. UK compounding pharmacies market, by solid preparations, 2014-2025 (USD Million)
  • TABLE 113. UK compounding pharmacies market, by liquid preparations, 2014-2025 (USD Million)
  • TABLE 114. UK compounding pharmacies market, by topical, 2014-2025 (USD Million)
  • TABLE 115. UK compounding pharmacies market, by rectal, 2014-2025 (USD Million)
  • TABLE 116. UK compounding pharmacies market, by parenteral, 2014-2025 (USD Million)
  • TABLE 117. Italy compounding pharmacies market, by product, 2014-2025 (USD Million)
  • TABLE 118. Italy compounding pharmacies market, by oral, 2014-2025 (USD Million)
  • TABLE 119. Italy compounding pharmacies market, by solid preparations, 2014-2025 (USD Million)
  • TABLE 120. Italy compounding pharmacies market, by liquid preparations, 2014-2025 (USD Million)
  • TABLE 121. Italy compounding pharmacies market, by topical, 2014-2025 (USD Million)
  • TABLE 122. Italy compounding pharmacies market, by rectal, 2014-2025 (USD Million)
  • TABLE 123. Italy compounding pharmacies market, by parenteral, 2014-2025 (USD Million)
  • TABLE 124. Italy compounding pharmacies market, by application, 2014-2025 (USD Million)
  • TABLE 125. Italy compounding pharmacies market, by therapeutic areas, 2014-2025 (USD Million)
  • TABLE 126. Italy compounding pharmacies market, by sterility, 2014-2025 (USD Million)
  • TABLE 127. Italy compounding pharmacies market, by distribution channel, 2014-2025 (USD Million)
  • TABLE 128. Spain compounding pharmacies market, by product, 2014-2025 (USD Million)
  • TABLE 129. Spain compounding pharmacies market, by oral, 2014-2025 (USD Million)
  • TABLE 130. Spain compounding pharmacies market, by solid preparations, 2014-2025 (USD Million)
  • TABLE 131. Spain compounding pharmacies market, by liquid preparations, 2014-2025 (USD Million)
  • TABLE 132. Spain compounding pharmacies market, by topical, 2014-2025 (USD Million)
  • TABLE 133. Spain compounding pharmacies market, by rectal, 2014-2025 (USD Million)
  • TABLE 134. Spain compounding pharmacies market, by parenteral, 2014-2025 (USD Million)
  • TABLE 135. Spain compounding pharmacies market, by application, 2014-2025 (USD Million)
  • TABLE 136. Spain compounding pharmacies market, by therapeutic areas, 2014-2025 (USD Million)
  • TABLE 137. Spain compounding pharmacies market, by sterility, 2014-2025 (USD Million)
  • TABLE 138. Spain compounding pharmacies market, by distribution channel, 2014-2025 (USD Million)
  • TABLE 139. France compounding pharmacies market, by product, 2014-2025 (USD Million)
  • TABLE 140. France compounding pharmacies market, by oral, 2014-2025 (USD Million)
  • TABLE 141. France compounding pharmacies market, by solid preparations, 2014-2025 (USD Million)
  • TABLE 142. France compounding pharmacies market, by liquid preparations, 2014-2025 (USD Million)
  • TABLE 143. France compounding pharmacies market, by topical, 2014-2025 (USD Million)
  • TABLE 144. France compounding pharmacies market, by rectal, 2014-2025 (USD Million)
  • TABLE 145. France compounding pharmacies market, by parenteral, 2014-2025 (USD Million)
  • TABLE 146. France compounding pharmacies market, by application, 2014-2025 (USD Million)
  • TABLE 147. France compounding pharmacies market, by therapeutic areas, 2014-2025 (USD Million)
  • TABLE 148. France compounding pharmacies market, by sterility, 2014-2025 (USD Million)
  • TABLE 149. France compounding pharmacies market, by distribution channel, 2014-2025 (USD Million)
  • TABLE 150. Poland compounding pharmacies market, by product, 2014-2025 (USD Million)
  • TABLE 151. Poland compounding pharmacies market, by oral, 2014-2025 (USD Million)
  • TABLE 152. Poland compounding pharmacies market, by solid preparations, 2014-2025 (USD Million)
  • TABLE 153. Poland compounding pharmacies market, by liquid preparations, 2014-2025 (USD Million)
  • TABLE 154. Poland compounding pharmacies market, by topical, 2014-2025 (USD Million)
  • TABLE 155. Poland compounding pharmacies market, by rectal, 2014-2025 (USD Million)
  • TABLE 156. Poland compounding pharmacies market, by parenteral, 2014-2025 (USD Million)
  • TABLE 157. Poland compounding pharmacies market, by application, 2014-2025 (USD Million)
  • TABLE 158. Poland compounding pharmacies market, by therapeutic areas, 2014-2025 (USD Million)
  • TABLE 159. Poland compounding pharmacies market, by sterility, 2014-2025 (USD Million)
  • TABLE 160. Poland compounding pharmacies market, by distribution channel, 2014-2025 (USD Million)
  • TABLE 161. Ukraine compounding pharmacies market, by product, 2014-2025 (USD Million)
  • TABLE 162. Ukraine compounding pharmacies market, by oral, 2014-2025 (USD Million)
  • TABLE 163. Ukraine compounding pharmacies market, by solid preparations, 2014-2025 (USD Million)
  • TABLE 164. Ukraine compounding pharmacies market, by liquid preparations, 2014-2025 (USD Million)
  • TABLE 165. Ukraine compounding pharmacies market, by topical, 2014-2025 (USD Million)
  • TABLE 166. Ukraine compounding pharmacies market, by rectal, 2014-2025 (USD Million)
  • TABLE 167. Ukraine compounding pharmacies market, by parenteral, 2014-2025 (USD Million)
  • TABLE 168. Ukraine compounding pharmacies market, by application, 2014-2025 (USD Million)
  • TABLE 169. Ukraine compounding pharmacies market, by therapeutic areas, 2014-2025 (USD Million)
  • TABLE 170. Ukraine compounding pharmacies market, by sterility, 2014-2025 (USD Million)
  • TABLE 171. Ukraine compounding pharmacies market, by distribution channel, 2014-2025 (USD Million)
  • TABLE 172. Greece compounding pharmacies market, by product, 2014-2025 (USD Million)
  • TABLE 173. Greece compounding pharmacies market, by oral, 2014-2025 (USD Million)
  • TABLE 174. Greece compounding pharmacies market, by solid preparations, 2014-2025 (USD Million)
  • TABLE 175. Greece compounding pharmacies market, by liquid preparations, 2014-2025 (USD Million)
  • TABLE 176. Greece compounding pharmacies market, by topical, 2014-2025 (USD Million)
  • TABLE 177. Greece compounding pharmacies market, by rectal, 2014-2025 (USD Million)
  • TABLE 178. Greece compounding pharmacies market, by parenteral, 2014-2025 (USD Million)
  • TABLE 179. Greece compounding pharmacies market, by application, 2014-2025 (USD Million)
  • TABLE 180. Greece compounding pharmacies market, by therapeutic areas, 2014-2025 (USD Million)
  • TABLE 181. Greece compounding pharmacies market, by sterility, 2014-2025 (USD Million)
  • TABLE 182. Greece compounding pharmacies market, by distribution channel, 2014-2025 (USD Million)
  • TABLE 183. Sweden compounding pharmacies market, by product, 2014-2025 (USD Million)
  • TABLE 184. Sweden compounding pharmacies market, by oral, 2014-2025 (USD Million)
  • TABLE 185. Sweden compounding pharmacies market, by solid preparations, 2014-2025 (USD Million)
  • TABLE 186. Sweden compounding pharmacies market, by liquid preparations, 2014-2025 (USD Million)
  • TABLE 187. Sweden compounding pharmacies market, by topical, 2014-2025 (USD Million)
  • TABLE 188. Sweden compounding pharmacies market, by rectal, 2014-2025 (USD Million)
  • TABLE 189. Sweden compounding pharmacies market, by parenteral, 2014-2025 (USD Million)
  • TABLE 190. Sweden compounding pharmacies market, by application, 2014-2025 (USD Million)
  • TABLE 191. Sweden compounding pharmacies market, by therapeutic areas, 2014-2025 (USD Million)
  • TABLE 192. Sweden compounding pharmacies market, by sterility, 2014-2025 (USD Million)
  • TABLE 193. Sweden compounding pharmacies market, by distribution channel, 2014-2025 (USD Million)
  • TABLE 194. Norway compounding pharmacies market, by product, 2014-2025 (USD Million)
  • TABLE 195. Norway compounding pharmacies market, by oral, 2014-2025 (USD Million)
  • TABLE 196. Norway compounding pharmacies market, by solid preparations, 2014-2025 (USD Million)
  • TABLE 197. Norway compounding pharmacies market, by liquid preparations, 2014-2025 (USD Million)
  • TABLE 198. Norway compounding pharmacies market, by topical, 2014-2025 (USD Million)
  • TABLE 199. Norway compounding pharmacies market, by rectal, 2014-2025 (USD Million)
  • TABLE 200. Norway compounding pharmacies market, by parenteral, 2014-2025 (USD Million)
  • TABLE 201. Norway compounding pharmacies market, by application, 2014-2025 (USD Million)
  • TABLE 202. Norway compounding pharmacies market, by therapeutic areas, 2014-2025 (USD Million)
  • TABLE 203. Norway compounding pharmacies market, by sterility, 2014-2025 (USD Million)
  • TABLE 204. Norway compounding pharmacies market, by distribution channel, 2014-2025 (USD Million)
  • TABLE 205. Belgium compounding pharmacies market, by product, 2014-2025 (USD Million)
  • TABLE 206. Belgium compounding pharmacies market, by oral, 2014-2025 (USD Million)
  • TABLE 207. Belgium compounding pharmacies market, by solid preparations, 2014-2025 (USD Million)
  • TABLE 208. Belgium compounding pharmacies market, by liquid preparations, 2014-2025 (USD Million)
  • TABLE 209. Belgium compounding pharmacies market, by topical, 2014-2025 (USD Million)
  • TABLE 210. Belgium compounding pharmacies market, by rectal, 2014-2025 (USD Million)
  • TABLE 211. Belgium compounding pharmacies market, by parenteral, 2014-2025 (USD Million)
  • TABLE 212. Belgium compounding pharmacies market, by application, 2014-2025 (USD Million)
  • TABLE 213. Belgium compounding pharmacies market, by therapeutic areas, 2014-2025 (USD Million)
  • TABLE 214. Belgium compounding pharmacies market, by sterility, 2014-2025 (USD Million)
  • TABLE 215. Belgium compounding pharmacies market, by distribution channel, 2014-2025 (USD Million)
  • TABLE 216. Czech Republic compounding pharmacies market, by product, 2014-2025 (USD Million)
  • TABLE 217. Czech Republic compounding pharmacies market, by oral, 2014-2025 (USD Million)
  • TABLE 218. Czech Republic compounding pharmacies market, by solid preparations, 2014-2025 (USD Million)
  • TABLE 219. Czech Republic compounding pharmacies market, by liquid preparations, 2014-2025 (USD Million)
  • TABLE 220. Czech Republic compounding pharmacies market, by topical, 2014-2025 (USD Million)
  • TABLE 221. Czech Republic compounding pharmacies market, by rectal, 2014-2025 (USD Million)
  • TABLE 222. Czech Republic compounding pharmacies market, by parenteral, 2014-2025 (USD Million)
  • TABLE 223. Czech Republic compounding pharmacies market, by application, 2014-2025 (USD Million)
  • TABLE 224. Czech Republic compounding pharmacies market, by therapeutic areas, 2014-2025 (USD Million)
  • TABLE 225. Czech Republic compounding pharmacies market, by sterility, 2014-2025 (USD Million)
  • TABLE 226. Czech Republic compounding pharmacies market, by distribution channel, 2014-2025 (USD Million)
  • TABLE 227. Finland compounding pharmacies market, by product, 2014-2025 (USD Million)
  • TABLE 228. Finland compounding pharmacies market, by oral, 2014-2025 (USD Million)
  • TABLE 229. Finland compounding pharmacies market, by solid preparations, 2014-2025 (USD Million)
  • TABLE 230. Finland compounding pharmacies market, by liquid preparations, 2014-2025 (USD Million)
  • TABLE 231. Finland compounding pharmacies market, by topical, 2014-2025 (USD Million)
  • TABLE 232. Finland compounding pharmacies market, by rectal, 2014-2025 (USD Million)
  • TABLE 233. Finland compounding pharmacies market, by parenteral, 2014-2025 (USD Million)
  • TABLE 234. Finland compounding pharmacies market, by application, 2014-2025 (USD Million)
  • TABLE 235. Finland compounding pharmacies market, by therapeutic areas, 2014-2025 (USD Million)
  • TABLE 236. Finland compounding pharmacies market, by sterility, 2014-2025 (USD Million)
  • TABLE 237. Finland compounding pharmacies market, by distribution channel, 2014-2025 (USD Million)
  • TABLE 238. Russia compounding pharmacies market, by product, 2014-2025 (USD Million)
  • TABLE 239. Russia compounding pharmacies market, by oral, 2014-2025 (USD Million)
  • TABLE 240. Russia compounding pharmacies market, by solid preparations, 2014-2025 (USD Million)
  • TABLE 241. Russia compounding pharmacies market, by liquid preparations, 2014-2025 (USD Million)
  • TABLE 242. Russia compounding pharmacies market, by topical, 2014-2025 (USD Million)
  • TABLE 243. Russia compounding pharmacies market, by rectal, 2014-2025 (USD Million)
  • TABLE 244. Russia compounding pharmacies market, by parenteral, 2014-2025 (USD Million)
  • TABLE 245. Russia compounding pharmacies market, by application, 2014-2025 (USD Million)
  • TABLE 246. Russia compounding pharmacies market, by therapeutic areas, 2014-2025 (USD Million)
  • TABLE 247. Russia compounding pharmacies market, by sterility, 2014-2025 (USD Million)
  • TABLE 248. Russia compounding pharmacies market, by distribution channel, 2014-2025 (USD Million)
  • TABLE 249. Asia Pacific compounding pharmacies market, by country, 2014-2025 (USD Million)
  • TABLE 250. Asia Pacific compounding pharmacies market, by product, 2014-2025 (USD Million)
  • TABLE 251. Asia Pacific compounding pharmacies market, by oral, 2014-2025 (USD Million)
  • TABLE 252. Asia Pacific compounding pharmacies market, by solid preparations, 2014-2025 (USD Million)
  • TABLE 253. Asia Pacific compounding pharmacies market, by liquid preparations, 2014-2025 (USD Million)
  • TABLE 254. Asia Pacific compounding pharmacies market, by topical, 2014-2025 (USD Million)
  • TABLE 255. Asia Pacific compounding pharmacies market, by rectal, 2014-2025 (USD Million)
  • TABLE 256. Asia Pacific compounding pharmacies market, by parenteral, 2014-2025 (USD Million)
  • TABLE 257. Asia Pacific compounding pharmacies market, by application, 2014-2025 (USD Million)
  • TABLE 258. Asia Pacific compounding pharmacies market, by therapeutic areas, 2014-2025 (USD Million)
  • TABLE 259. Asia Pacific compounding pharmacies market, by sterility, 2014-2025 (USD Million)
  • TABLE 260. Asia Pacific compounding pharmacies market, by distribution channel, 2014-2025 (USD Million)
  • TABLE 261. China compounding pharmacies market, by product, 2014-2025 (USD Million)
  • TABLE 262. China compounding pharmacies market, by oral, 2014-2025 (USD Million)
  • TABLE 263. China compounding pharmacies market, by solid preparations, 2014-2025 (USD Million)
  • TABLE 264. China compounding pharmacies market, by liquid preparations, 2014-2025 (USD Million)
  • TABLE 265. China compounding pharmacies market, by topical, 2014-2025 (USD Million)
  • TABLE 266. China compounding pharmacies market, by rectal, 2014-2025 (USD Million)
  • TABLE 267. China compounding pharmacies market, by parenteral, 2014-2025 (USD Million)
  • TABLE 268. China compounding pharmacies market, by application, 2014-2025 (USD Million)
  • TABLE 269. China compounding pharmacies market, by therapeutic areas, 2014-2025 (USD Million)
  • TABLE 270. China compounding pharmacies market, by sterility, 2014-2025 (USD Million)
  • TABLE 271. China compounding pharmacies market, by distribution channel, 2014-2025 (USD Million)
  • TABLE 272. India compounding pharmacies market, by product, 2014-2025 (USD Million)
  • TABLE 273. India compounding pharmacies market, by oral, 2014-2025 (USD Million)
  • TABLE 274. India compounding pharmacies market, by solid preparations, 2014-2025 (USD Million)
  • TABLE 275. India compounding pharmacies market, by liquid preparations, 2014-2025 (USD Million)
  • TABLE 276. India compounding pharmacies market, by topical, 2014-2025 (USD Million)
  • TABLE 277. India compounding pharmacies market, by rectal, 2014-2025 (USD Million)
  • TABLE 278. India compounding pharmacies market, by parenteral, 2014-2025 (USD Million)
  • TABLE 279. India compounding pharmacies market, by application, 2014-2025 (USD Million)
  • TABLE 280. India compounding pharmacies market, by therapeutic areas, 2014-2025 (USD Million)
  • TABLE 281. India compounding pharmacies market, by sterility, 2014-2025 (USD Million)
  • TABLE 282. India compounding pharmacies market, by distribution channel, 2014-2025 (USD Million)
  • TABLE 283. Japan compounding pharmacies market, by product, 2014-2025 (USD Million)
  • TABLE 284. Japan compounding pharmacies market, by oral, 2014-2025 (USD Million)
  • TABLE 285. Japan compounding pharmacies market, by solid preparations, 2014-2025 (USD Million)
  • TABLE 286. Japan compounding pharmacies market, by liquid preparations, 2014-2025 (USD Million)
  • TABLE 287. Japan compounding pharmacies market, by topical, 2014-2025 (USD Million)
  • TABLE 288. Japan compounding pharmacies market, by rectal, 2014-2025 (USD Million)
  • TABLE 289. Japan compounding pharmacies market, by parenteral, 2014-2025 (USD Million)
  • TABLE 290. Japan compounding pharmacies market, by application, 2014-2025 (USD Million)
  • TABLE 291. Japan compounding pharmacies market, by therapeutic areas, 2014-2025 (USD Million)
  • TABLE 292. Japan compounding pharmacies market, by sterility, 2014-2025 (USD Million)
  • TABLE 293. Japan compounding pharmacies market, by distribution channel, 2014-2025 (USD Million)
  • TABLE 294. Singapore compounding pharmacies market, by product, 2014-2025 (USD Million)
  • TABLE 295. Singapore compounding pharmacies market, by oral, 2014-2025 (USD Million)
  • TABLE 296. Singapore compounding pharmacies market, by solid preparations, 2014-2025 (USD Million)
  • TABLE 297. Singapore compounding pharmacies market, by liquid preparations, 2014-2025 (USD Million)
  • TABLE 298. Singapore compounding pharmacies market, by topical, 2014-2025 (USD Million)
  • TABLE 299. Singapore compounding pharmacies market, by rectal, 2014-2025 (USD Million)
  • TABLE 300. Singapore compounding pharmacies market, by parenteral, 2014-2025 (USD Million)
  • TABLE 301. Singapore compounding pharmacies market, by application, 2014-2025 (USD Million)
  • TABLE 302. Singapore compounding pharmacies market, by therapeutic areas, 2014-2025 (USD Million)
  • TABLE 303. Singapore compounding pharmacies market, by sterility, 2014-2025 (USD Million)
  • TABLE 304. Singapore compounding pharmacies market, by distribution channel, 2014-2025 (USD Million)
  • TABLE 305. Australia compounding pharmacies market, by product, 2014-2025 (USD Million)
  • TABLE 306. Australia compounding pharmacies market, by oral, 2014-2025 (USD Million)
  • TABLE 307. Australia compounding pharmacies market, by solid preparations, 2014-2025 (USD Million)
  • TABLE 308. Australia compounding pharmacies market, by liquid preparations, 2014-2025 (USD Million)
  • TABLE 309. Australia compounding pharmacies market, by topical, 2014-2025 (USD Million)
  • TABLE 310. Australia compounding pharmacies market, by rectal, 2014-2025 (USD Million)
  • TABLE 311. Australia compounding pharmacies market, by parenteral, 2014-2025 (USD Million)
  • TABLE 312. Australia compounding pharmacies market, by application, 2014-2025 (USD Million)
  • TABLE 313. Australia compounding pharmacies market, by therapeutic areas, 2014-2025 (USD Million)
  • TABLE 314. Australia compounding pharmacies market, by sterility, 2014-2025 (USD Million)
  • TABLE 315. Australia compounding pharmacies market, by distribution channel, 2014-2025 (USD Million)
  • TABLE 316. Latin America compounding pharmacies market, by country 2014 - 2025 (USD Million)
  • TABLE 317. Latin America compounding pharmacies market, by product, 2014-2025 (USD Million)
  • TABLE 318. Latin America compounding pharmacies market, by oral, 2014-2025 (USD Million)
  • TABLE 319. Latin America compounding pharmacies market, by solid preparations, 2014-2025 (USD Million)
  • TABLE 320. Latin America compounding pharmacies market, by liquid preparations, 2014-2025 (USD Million)
  • TABLE 321. Latin America compounding pharmacies market, by topical, 2014-2025 (USD Million)
  • TABLE 322. Latin America compounding pharmacies market, by rectal, 2014-2025 (USD Million)
  • TABLE 323. Latin America compounding pharmacies market, by parenteral, 2014-2025 (USD Million)
  • TABLE 324. Latin America compounding pharmacies market, by application, 2014-2025 (USD Million)
  • TABLE 325. Latin America compounding pharmacies market, by therapeutic areas, 2014-2025 (USD Million)
  • TABLE 326. Latin America compounding pharmacies market, by sterility, 2014-2025 (USD Million)
  • TABLE 327. Latin America compounding pharmacies market, by distribution channel, 2014-2025 (USD Million)
  • TABLE 328. Argentina compounding pharmacies market, by product, 2014-2025 (USD Million)
  • TABLE 329. Argentina compounding pharmacies market, by oral, 2014-2025 (USD Million)
  • TABLE 330. Argentina compounding pharmacies market, by solid preparations, 2014-2025 (USD Million)
  • TABLE 331. Argentina compounding pharmacies market, by liquid preparations, 2014-2025 (USD Million)
  • TABLE 332. Argentina compounding pharmacies market, by topical, 2014-2025 (USD Million)
  • TABLE 333. Argentina compounding pharmacies market, by rectal, 2014-2025 (USD Million)
  • TABLE 334. Argentina compounding pharmacies market, by parenteral, 2014-2025 (USD Million)
  • TABLE 335. Argentina compounding pharmacies market, by application, 2014-2025 (USD Million)
  • TABLE 336. Argentina compounding pharmacies market, by therapeutic areas, 2014-2025 (USD Million)
  • TABLE 337. Argentina compounding pharmacies market, by sterility, 2014-2025 (USD Million)
  • TABLE 338. Argentina compounding pharmacies market, by distribution channel, 2014-2025 (USD Million)
  • TABLE 339. Brazil compounding pharmacies market, by product, 2014-2025 (USD Million)
  • TABLE 340. Brazil compounding pharmacies market, by oral, 2014-2025 (USD Million)
  • TABLE 341. Brazil compounding pharmacies market, by solid preparations, 2014-2025 (USD Million)
  • TABLE 342. Brazil compounding pharmacies market, by liquid preparations, 2014-2025 (USD Million)
  • TABLE 343. Brazil compounding pharmacies market, by topical, 2014-2025 (USD Million)
  • TABLE 344. Brazil compounding pharmacies market, by rectal, 2014-2025 (USD Million)
  • TABLE 345. Brazil compounding pharmacies market, by parenteral, 2014-2025 (USD Million)
  • TABLE 346. Brazil compounding pharmacies market, by application, 2014-2025 (USD Million)
  • TABLE 347. Brazil compounding pharmacies market, by therapeutic areas, 2014-2025 (USD Million)
  • TABLE 348. Brazil compounding pharmacies market, by sterility, 2014-2025 (USD Million)
  • TABLE 349. Brazil compounding pharmacies market, by distribution channel, 2014-2025 (USD Million)
  • TABLE 350. Mexico compounding pharmacies market, by product, 2014-2025 (USD Million)
  • TABLE 351. Mexico compounding pharmacies market, by oral, 2014-2025 (USD Million)
  • TABLE 352. Mexico compounding pharmacies market, by solid preparations, 2014-2025 (USD Million)
  • TABLE 353. Mexico compounding pharmacies market, by liquid preparations, 2014-2025 (USD Million)
  • TABLE 354. Mexico compounding pharmacies market, by topical, 2014-2025 (USD Million)
  • TABLE 355. Mexico compounding pharmacies market, by rectal, 2014-2025 (USD Million)
  • TABLE 356. Mexico compounding pharmacies market, by parenteral, 2014-2025 (USD Million)
  • TABLE 357. Mexico compounding pharmacies market, by application, 2014-2025 (USD Million)
  • TABLE 358. Mexico compounding pharmacies market, by therapeutic areas, 2014-2025 (USD Million)
  • TABLE 359. Mexico compounding pharmacies market, by sterility, 2014-2025 (USD Million)
  • TABLE 360. Mexico compounding pharmacies market, by distribution channel, 2014-2025 (USD Million)
  • TABLE 361. MEA compounding pharmacies market, by country 2014 - 2025 (USD Million)
  • TABLE 362. MEA compounding pharmacies market, by product, 2014-2025 (USD Million)
  • TABLE 363. MEA compounding pharmacies market, by oral, 2014-2025 (USD Million)
  • TABLE 364. MEA compounding pharmacies market, by solid preparations, 2014-2025 (USD Million)
  • TABLE 365. MEA compounding pharmacies market, by liquid preparations, 2014-2025 (USD Million)
  • TABLE 366. MEA compounding pharmacies market, by topical, 2014-2025 (USD Million)
  • TABLE 367. MEA compounding pharmacies market, by rectal, 2014-2025 (USD Million)
  • TABLE 368. MEA compounding pharmacies market, by parenteral, 2014-2025 (USD Million)
  • TABLE 369. MEA compounding pharmacies market, by application, 2014-2025 (USD Million)
  • TABLE 370. MEA compounding pharmacies market, by therapeutic areas, 2014-2025 (USD Million)
  • TABLE 371. MEA compounding pharmacies market, by sterility, 2014-2025 (USD Million)
  • TABLE 372. MEA compounding pharmacies market, by distribution channel, 2014-2025 (USD Million)
  • TABLE 373. South Africa compounding pharmacies market, by product, 2014-2025 (USD Million)
  • TABLE 374. South Africa compounding pharmacies market, by oral, 2014-2025 (USD Million)
  • TABLE 375. South Africa compounding pharmacies market, by solid preparations, 2014-2025 (USD Million)
  • TABLE 376. South Africa compounding pharmacies market, by liquid preparations, 2014-2025 (USD Million)
  • TABLE 377. South Africa compounding pharmacies market, by topical, 2014-2025 (USD Million)
  • TABLE 378. South Africa compounding pharmacies market, by rectal, 2014-2025 (USD Million)
  • TABLE 379. South Africa compounding pharmacies market, by parenteral, 2014-2025 (USD Million)
  • TABLE 380. South Africa compounding pharmacies market, by application, 2014-2025 (USD Million)
  • TABLE 381. South Africa compounding pharmacies market, by therapeutic areas, 2014-2025 (USD Million)
  • TABLE 382. South Africa compounding pharmacies market, by sterility, 2014-2025 (USD Million)
  • TABLE 383. South Africa compounding pharmacies market, by distribution channel, 2014-2025 (USD Million)
  • TABLE 384. UAE compounding pharmacies market, by product, 2014-2025 (USD Million)
  • TABLE 385. UAE compounding pharmacies market, by oral, 2014-2025 (USD Million)
  • TABLE 386. UAE compounding pharmacies market, by solid preparations, 2014-2025 (USD Million)
  • TABLE 387. UAE compounding pharmacies market, by liquid preparations, 2014-2025 (USD Million)
  • TABLE 388. UAE compounding pharmacies market, by topical, 2014-2025 (USD Million)
  • TABLE 389. UAE compounding pharmacies market, by rectal, 2014-2025 (USD Million)
  • TABLE 390. UAE compounding pharmacies market, by parenteral, 2014-2025 (USD Million)
  • TABLE 391. UAE compounding pharmacies market, by application, 2014-2025 (USD Million)
  • TABLE 392. UAE compounding pharmacies market, by therapeutic areas, 2014-2025 (USD Million)
  • TABLE 393. UAE compounding pharmacies market, by sterility, 2014-2025 (USD Million)
  • TABLE 394. UAE compounding pharmacies market, by distribution channel, 2014-2025 (USD Million)
  • TABLE 395. Saudi Arabia compounding pharmacies market, by product, 2014-2025 (USD Million)
  • TABLE 396. Saudi Arabia compounding pharmacies market, by oral, 2014-2025 (USD Million)
  • TABLE 397. Saudi Arabia compounding pharmacies market, by solid preparations, 2014-2025 (USD Million)
  • TABLE 398. Saudi Arabia compounding pharmacies market, by liquid preparations, 2014-2025 (USD Million)
  • TABLE 399. Saudi Arabia compounding pharmacies market, by topical, 2014-2025 (USD Million)
  • TABLE 400. Saudi Arabia compounding pharmacies market, by rectal, 2014-2025 (USD Million)
  • TABLE 401. Saudi Arabia compounding pharmacies market, by parenteral, 2014-2025 (USD Million)
  • TABLE 402. Saudi Arabia compounding pharmacies market, by application, 2014-2025 (USD Million)
  • TABLE 403. Saudi Arabia compounding pharmacies market, by therapeutic areas, 2014-2025 (USD Million)
  • TABLE 404. Saudi Arabia compounding pharmacies market, by sterility, 2014-2025 (USD Million)
  • TABLE 405. Saudi Arabia compounding pharmacies market, by distribution channel, 2014-2025 (USD Million)
  • TABLE 406. Qatar compounding pharmacies market, by product, 2014-2025 (USD Million)
  • TABLE 407. Qatar compounding pharmacies market, by oral, 2014-2025 (USD Million)
  • TABLE 408. Qatar compounding pharmacies market, by solid preparations, 2014-2025 (USD Million)
  • TABLE 409. Qatar compounding pharmacies market, by liquid preparations, 2014-2025 (USD Million)
  • TABLE 410. Qatar compounding pharmacies market, by topical, 2014-2025 (USD Million)
  • TABLE 411. Qatar compounding pharmacies market, by rectal, 2014-2025 (USD Million)
  • TABLE 412. Qatar compounding pharmacies market, by parenteral, 2014-2025 (USD Million)
  • TABLE 413. Qatar compounding pharmacies market, by application, 2014-2025 (USD Million)
  • TABLE 414. Qatar compounding pharmacies market, by therapeutic areas, 2014-2025 (USD Million)
  • TABLE 415. Qatar compounding pharmacies market, by sterility, 2014-2025 (USD Million)
  • TABLE 416. Qatar compounding pharmacies market, by distribution channel, 2014-2025 (USD Million)
  • TABLE 417. Kuwait compounding pharmacies market, by product, 2014-2025 (USD Million)
  • TABLE 418. Kuwait compounding pharmacies market, by oral, 2014-2025 (USD Million)
  • TABLE 419. Kuwait compounding pharmacies market, by solid preparations, 2014-2025 (USD Million)
  • TABLE 420. Kuwait compounding pharmacies market, by liquid preparations, 2014-2025 (USD Million)
  • TABLE 421. Kuwait compounding pharmacies market, by topical, 2014-2025 (USD Million)
  • TABLE 422. Kuwait compounding pharmacies market, by rectal, 2014-2025 (USD Million)
  • TABLE 423. Kuwait compounding pharmacies market, by parenteral, 2014-2025 (USD Million)
  • TABLE 424. Kuwait compounding pharmacies market, by application, 2014-2025 (USD Million)
  • TABLE 425. Kuwait compounding pharmacies market, by therapeutic areas, 2014-2025 (USD Million)
  • TABLE 426. Kuwait compounding pharmacies market, by sterility, 2014-2025 (USD Million)
  • TABLE 427. Kuwait compounding pharmacies market, by distribution channel, 2014-2025 (USD Million)

Charts & Figures

  • FIG. 1 Industry segmentation
  • FIG. 2 Compounding pharmacies market, 2014 - 2025 (USD Million)
  • FIG. 3 Industry ecosystem analysis
  • FIG. 4 Vendor Matrix
  • FIG. 5 Distribution channel analysis
  • FIG. 6 Global population of person aged 60 years or over, 2000-2050
  • FIG. 7 Growth potential analysis, product
  • FIG. 8 Growth potential analysis, therapeutic areas
  • FIG. 9 Growth potential analysis, application
  • FIG. 10 Growth potential analysis, distribution channel
  • FIG. 11 Growth potential analysis, sterility
  • FIG. 12 Market share by prescriber's specialty
  • FIG. 13 Porter's Analysis
  • FIG. 14 Strategic Dashboard
  • FIG. 15 PESTEL Analysis
Back to Top